$47.15

+0.18 (+0.38%)

Weekly Expected Move ±4.4%

$43 $45 $47 $49 $51

NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $872.4M mcap · 18M float · 1.83% daily turnover · Short 61% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

47.9 / 100

NoneWeakNarrowWide

Primary source: Switching Costs · ROIC: 88.5%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. RIGL shows a Weak competitive edge (47.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 88.5% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$49

Low

$67

Avg Target

$85

High

Based on 2 analysts since Aug 4, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 8Hold: 7Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$67.00

Analysts2

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-08-17	Piper Sandler	—	$2	$49	+47	+15.1%	$42.58
2026-08-14	H.C. Wainwright	Joseph Pantginis	Initiated	$85	—	+103.7%	$41.74
2025-11-05	Jefferies	—	$1	$42	+41	+11.0%	$37.85
2025-11-05	Cantor Fitzgerald	—	Initiated	$38	—	+1.0%	$37.63
2022-08-17	Piper Sandler	—	Initiated	$2	—	+28.2%	$1.56
2022-06-08	Jefferies	Eun Yang	Initiated	$1	—	+41.0%	$0.71

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. RIGL receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (2/5).

Rating Change History

Date	From	To
2026-10-01	A-	B+
2026-05-11	A	A-
2026-05-05	A-	A
2026-04-22	B+	A-
2026-04-01	A-	B+
2026-03-03	B+	A-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 71 Grade B

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. RIGL scores highest in Profitability (96/100) and lowest in Earnings Quality (12/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

3.45

Safe Zone

Piotroski F-Score

4/9

✓ ✓ ✓ ✗ ✓ ✗ ✗ ✗ ✗

Beneish M-Score

1.78

Possible Manipulator

Ohlson O-Score

-11.86

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

Score: 89.4/100

Trend: Improving

Earnings Quality

25/100

OCF/NI: 0.25x

Accruals: 66.6%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. RIGL scores 3.45, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. RIGL scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. RIGL's score of 1.78 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. RIGL's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. RIGL receives an estimated rating of AA (score: 89.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). RIGL's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

2.67x

PEG

0.01x

P/S

3.15x

P/B

2.05x

P/FCF

9.64x

P/OCF

9.64x

EV/EBITDA

7.55x

EV/Revenue

2.57x

EV/EBIT

7.77x

EV/FCF

8.95x

Earnings Yield

42.05%

FCF Yield

10.37%

Shareholder Yield

0.00%

Graham Number

$89.70

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 2.7x earnings, RIGL trades at a deep value multiple. An earnings yield of 42.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $89.70 per share, suggesting a potential 90% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

3.762

NI / EBT

Interest Burden

0.936

EBT / EBIT

EBIT Margin

0.330

EBIT / Rev

Asset Turnover

0.761

Rev / Assets

Equity Multiplier

1.434

Assets / Equity

ROE

126.9%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. RIGL's ROE of 126.9% is driven by Asset Turnover (0.761), indicating efficient use of assets to generate revenue. A tax burden ratio of 3.76 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

15.00%

Fair P/E

38.50x

Intrinsic Value

$633.29

Price/Value

0.06x

Margin of Safety

93.82%

Premium

-93.82%

Assessment

Undervalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with RIGL's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $633.29, RIGL appears undervalued with a 94% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 2.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$47.15

Median 1Y

$36.12

5th Pctile

$8.93

95th Pctile

$148.61

Ann. Volatility

86.7%

Analyst Target

$67.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Raul R. Rodriguez President and Chief Executive Officer	$787,405	$951,327	$4,658,805
David A. Santos Executive Vice President and Chief Commercial Officer	$515,920	$443,435	$1,831,604
Lisa Rojkjaer, M.D. Executive Vice President and Chief Medical Officer	$517,280	$443,435	$1,830,175
Dean L. Schorno Executive Vice President and Chief Financial Officer	$514,950	$443,435	$1,822,409
Raymond J. Furey Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary	$480,480	$443,435	$1,769,502

CEO Pay Ratio

7:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $4,658,805

Avg Employee Cost (SGA/emp): $673,837

Employees: 172

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

172

+6.2% YoY

Revenue / Employee

$1,710,942

Rev: $294,282,000

Profit / Employee

$2,133,860

NI: $367,024,000

SGA / Employee

$673,837

Avg labor cost proxy

R&D / Employee

$193,576

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	-28.8%	-55.6%	-2.0%	-2.6%	-5.5%	-7.0%	5.1%	2.4%	94.6%	1.2%	70.8%	49.1%	-16.7%	-1.4%	-5.7%	3.8%	2.2%	1.9%	1.7%	1.3%	1.27%
ROA	-9.4%	-12.9%	-46.5%	-51.3%	-54.7%	-38.8%	-32.8%	-30.8%	-21.2%	-20.0%	-15.8%	-11.6%	3.0%	12.4%	24.6%	58.4%	59.3%	1.1%	1.1%	88.5%	88.46%
ROIC	12.9%	15.4%	1.0%	1.1%	1.1%	1.4%	1.5%	85.2%	48.2%	64.8%	56.2%	38.1%	-61.2%	-1.6%	16.9%	3.0%	2.9%	1.3%	1.2%	88.5%	88.49%
ROCE	-7.7%	-12.0%	-89.5%	-1.1%	-1.2%	-79.4%	-52.4%	-44.9%	-27.4%	-28.5%	-23.0%	-9.4%	13.8%	26.1%	42.1%	89.0%	82.3%	31.2%	31.0%	21.5%	21.47%
Gross Margin	99.3%	97.6%	99.3%	96.5%	98.9%	99.3%	96.3%	96.0%	95.5%	89.4%	93.1%	92.4%	85.5%	89.9%	91.7%	95.6%	93.2%	91.5%	92.2%	89.2%	89.17%
Operating Margin	-91.8%	-1.0%	-1.6%	-43.5%	-82.1%	4.1%	-48.8%	-19.6%	-15.9%	5.5%	-23.6%	1.2%	25.4%	28.9%	23.9%	60.1%	40.9%	33.2%	20.2%	30.0%	29.95%
Net Margin	-97.3%	-1.1%	-1.6%	-45.2%	-84.9%	2.7%	-51.9%	-24.5%	-20.2%	2.1%	-27.9%	-2.8%	22.5%	24.9%	21.5%	58.6%	40.2%	3.8%	14.7%	22.0%	21.97%
EBITDA Margin	-90.6%	-1.0%	-1.6%	-42.5%	-80.2%	5.4%	-45.9%	-16.5%	-12.4%	8.2%	-20.2%	4.4%	27.3%	30.9%	26.2%	61.4%	43.4%	35.8%	23.3%	32.0%	32.03%
FCF Margin	5.6%	3.5%	-0.7%	-77.1%	-79.8%	-61.7%	-52.0%	-38.4%	-27.6%	-17.7%	-5.7%	-9.7%	6.6%	17.3%	17.4%	24.6%	24.2%	25.7%	26.4%	28.7%	28.68%
OCF Margin	6.4%	3.9%	0.2%	-76.8%	-79.4%	-61.3%	-40.3%	-26.3%	-16.2%	-4.9%	-5.6%	-9.4%	6.8%	17.6%	17.5%	24.6%	24.2%	25.7%	26.4%	28.7%	28.68%
ROA 3Y Avg	snapshot only																				32.67%
ROIC Economic	snapshot only																				71.21%
Cash ROA	snapshot only																				15.24%
Cash ROIC	snapshot only																				21.45%
CROIC	snapshot only																				21.45%
NOPAT Margin	snapshot only																				1.18%
Pretax Margin	snapshot only																				30.92%
R&D / Revenue	snapshot only																				15.78%
SGA / Revenue	snapshot only																				44.16%
SBC / Revenue	snapshot only																				5.93%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	-42.75	-25.31	-6.05	-2.30	-2.47	-4.43	-5.13	-5.93	-7.71	-10.08	-13.09	-10.14	73.58	17.30	8.79	3.48	4.79	2.20	1.46	2.38	2.668
P/S Ratio	4.21	3.04	6.05	2.20	2.28	2.16	1.77	1.77	1.42	2.16	2.15	1.11	1.81	1.69	1.61	1.27	1.92	2.74	1.78	2.77	3.152
P/B Ratio	12.49	14.93	75.55	-52.90	-10.28	-19.04	-9.45	-7.96	-5.92	-8.83	-8.19	-4.82	-19.51	92.01	17.60	4.15	4.61	2.06	1.33	1.80	2.055
P/FCF	75.28	86.33	-879.46	-2.85	-2.86	-3.49	-3.40	-4.61	-5.16	-12.20	-38.02	-11.39	27.57	9.74	9.25	5.17	7.96	10.67	6.71	9.64	9.643
P/OCF	66.05	77.12	2620.43	—	—	—	—	—	—	—	—	—	26.62	9.61	9.18	5.17	7.96	10.67	6.71	9.64	9.643
EV/EBITDA	-57.36	-31.80	-5.60	-1.78	-2.13	-4.50	-5.80	-6.97	-10.90	-15.11	-24.61	-31.57	20.83	10.00	6.42	2.68	3.75	5.36	3.29	7.55	7.553
EV/Revenue	3.46	2.41	5.23	1.59	1.85	2.02	1.78	1.74	1.41	2.20	2.25	1.19	1.81	1.59	1.53	1.09	1.65	2.40	1.44	2.57	2.566
EV/EBIT	-51.74	-28.83	-5.52	-1.76	-2.10	-4.42	-5.64	-6.72	-10.17	-14.09	-22.04	-23.84	24.22	10.85	6.75	2.74	3.83	5.46	3.35	7.77	7.772
EV/FCF	61.89	68.36	-760.66	-2.07	-2.32	-3.27	-3.43	-4.53	-5.12	-12.37	-39.63	-12.27	27.48	9.18	8.80	4.45	6.85	9.32	5.44	8.95	8.946
Earnings Yield	-2.3%	-4.0%	-16.5%	-43.5%	-40.5%	-22.6%	-19.5%	-16.9%	-13.0%	-9.9%	-7.6%	-9.9%	1.4%	5.8%	11.4%	28.8%	20.9%	45.5%	68.4%	42.0%	42.05%
FCF Yield	1.3%	1.2%	-0.1%	-35.1%	-35.0%	-28.6%	-29.4%	-21.7%	-19.4%	-8.2%	-2.6%	-8.8%	3.6%	10.3%	10.8%	19.3%	12.6%	9.4%	14.9%	10.4%	10.37%
PEG Ratio	snapshot only																				0.012
Price/Tangible Book	snapshot only																				2.309
EV/OCF	snapshot only																				8.946
EV/Gross Profit	snapshot only																				2.808
Acquirers Multiple	snapshot only																				8.159
Shareholder Yield	snapshot only																				0.00%
Graham Number	snapshot only																				$89.70

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	2.89	2.43	2.35	2.19	2.34	1.78	2.35	2.29	1.97	1.86	1.26	1.62	1.96	2.13	2.20	2.02	2.28	2.42	2.62	1.95	1.946
Quick Ratio	2.77	2.33	2.23	2.08	2.19	1.64	2.11	2.05	1.84	1.76	1.17	1.48	1.87	2.04	2.13	1.90	2.06	2.30	2.48	1.79	1.795
Debt/Equity	0.66	1.01	5.61	-9.69	-2.16	-3.05	-2.50	-2.16	-1.91	-2.11	-1.91	-2.02	-4.12	18.24	3.29	0.75	0.52	0.14	0.11	0.09	0.094
Net Debt/Equity	-2.22	-3.11	-10.21	—	—	—	—	—	—	—	—	—	—	-5.28	-0.86	-0.58	-0.65	-0.26	-0.25	-0.13	-0.130
Debt/Assets	0.18	0.18	0.26	0.28	0.37	0.31	0.49	0.52	0.53	0.52	0.48	0.47	0.43	0.37	0.35	0.30	0.25	0.10	0.09	0.08	0.077
Debt/EBITDA	-3.69	-2.71	-0.48	-0.45	-0.55	-0.77	-1.52	-1.92	-3.55	-3.57	-5.51	-12.25	4.41	2.10	1.26	0.56	0.49	0.41	0.35	0.42	0.425
Net Debt/EBITDA	12.41	8.36	0.88	0.68	0.50	0.31	-0.05	0.12	0.09	-0.21	-1.00	-2.28	-0.06	-0.61	-0.33	-0.43	-0.61	-0.77	-0.77	-0.59	-0.589
Interest Coverage	-2.47	-2.56	-14.42	-18.30	-20.20	-14.80	-11.05	-6.56	-3.02	-2.65	-1.63	-0.85	1.49	3.32	5.83	13.80	16.09	17.64	18.68	15.74	15.742
Equity Multiplier	3.76	5.51	21.93	-34.81	-5.83	-9.86	-5.10	-4.16	-3.62	-4.09	-3.99	-4.29	-9.53	49.87	9.48	2.52	2.06	1.31	1.26	1.22	1.225
Cash Ratio	snapshot only																				1.000
Debt Service Coverage	snapshot only																				16.198
Cash to Debt	snapshot only																				2.386
FCF to Debt	snapshot only																				1.987
Defensive Interval	snapshot only																				333.0 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.95	1.07	0.47	0.54	0.59	0.80	0.95	1.03	1.15	0.93	0.96	1.06	1.24	1.28	1.34	1.60	1.48	0.87	0.88	0.76	0.761
Inventory Turnover	0.20	0.26	0.13	0.28	0.27	0.22	0.29	0.31	0.55	0.97	0.92	1.05	3.06	3.24	3.74	2.46	1.53	2.24	2.43	1.92	1.923
Receivables Turnover	9.94	9.49	1.08	5.12	5.86	4.31	5.81	6.66	6.78	3.30	4.23	5.24	5.82	4.97	5.88	7.79	7.37	6.30	6.55	5.77	5.769
Payables Turnover	0.34	0.29	0.18	0.93	0.65	0.13	0.48	0.72	0.68	0.48	1.05	1.74	2.82	3.56	3.18	3.39	5.08	3.73	4.70	4.22	4.219
DSO	37	38	338	71	62	85	63	55	54	111	86	70	63	73	62	47	49	58	56	63	63.3 days
DIO	1808	1391	2818	1327	1364	1642	1250	1173	659	376	395	348	119	113	98	148	238	163	150	190	189.8 days
DPO	1080	1264	1995	391	565	2745	764	510	534	761	348	210	130	103	115	108	72	98	78	87	86.5 days
Cash Conversion Cycle	765	165	1161	1007	861	-1018	548	718	179	-275	133	208	53	84	45	88	216	123	128	167	166.5 days
Fixed Asset Turnover	snapshot only																				427.798
Operating Cycle	snapshot only																				253.0 days
Cash Velocity	snapshot only																				2.903
Capital Intensity	snapshot only																				1.883

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	39.5%	37.4%	-36.5%	-38.6%	-39.3%	-19.4%	52.5%	43.1%	48.1%	-2.8%	-7.1%	2.9%	19.0%	53.4%	68.7%	1.1%	79.1%	64.1%	47.6%	3.3%	3.31%
Net Income	47.6%	39.8%	-6.4%	-9.9%	-4.7%	-2.3%	47.4%	55.3%	70.4%	57.2%	55.7%	62.3%	1.2%	1.7%	2.9%	7.9%	28.2%	20.0%	8.8%	2.3%	2.29%
EPS	48.2%	40.5%	-6.6%	-9.8%	-4.6%	-2.2%	47.9%	55.7%	70.7%	57.6%	56.1%	62.7%	1.2%	1.7%	2.8%	7.6%	25.9%	19.0%	8.0%	2.1%	2.05%
FCF	1.2%	1.1%	99.2%	-69.4%	-9.7%	-15.1%	-114.4%	28.8%	48.8%	72.0%	89.9%	73.9%	1.3%	2.5%	6.2%	6.2%	5.6%	1.4%	1.2%	20.7%	20.67%
EBITDA	65.5%	59.2%	-9.9%	-25.7%	-7.7%	-3.8%	49.8%	60.1%	77.9%	68.5%	72.4%	84.4%	1.8%	2.7%	5.4%	23.2%	8.1%	3.6%	1.7%	-14.0%	-13.97%
Op. Income	64.0%	56.9%	-8.8%	-19.6%	-7.0%	-3.4%	47.8%	57.3%	74.2%	63.1%	64.9%	73.7%	1.5%	2.2%	4.0%	12.6%	11.5%	4.2%	1.8%	-16.8%	-16.77%
OCF Growth	snapshot only																				20.60%
Asset Growth	snapshot only																				1.52%
Equity Growth	snapshot only																				4.19%
Debt Growth	snapshot only																				-34.56%
Shares Change	snapshot only																				7.75%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	1.8%	49.7%	14.1%	10.4%	3.0%	26.6%	8.2%	5.4%	7.8%	2.5%	-3.5%	-3.3%	2.3%	6.3%	33.7%	44.7%	46.7%	34.8%	32.3%	29.8%	29.77%
Revenue 5Y	41.5%	48.9%	35.0%	53.6%	64.2%	93.1%	1.7%	1.2%	81.9%	21.3%	16.1%	14.7%	14.0%	24.8%	14.7%	19.9%	21.7%	22.1%	17.5%	13.9%	13.94%
EPS 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EBITDA 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Profit 3Y	—	65.0%	14.0%	10.0%	2.7%	26.6%	7.8%	5.0%	7.1%	0.6%	-5.5%	-5.6%	-1.3%	2.7%	29.4%	41.4%	44.3%	32.3%	30.2%	26.8%	26.82%
Gross Profit 5Y	—	—	—	—	—	—	—	—	—	27.2%	14.6%	13.1%	11.7%	22.4%	12.4%	18.0%	20.2%	20.6%	16.1%	12.0%	12.05%
Op. Income 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	7.9%	80.9%	—	—	—	—	—	—	—
FCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
OCF 3Y	—	—	—	—	—	—	—	—	—	—	—	—	4.5%	74.9%	4.7%	—	—	—	—	—	—
OCF 5Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.3%	2.29%
Assets 3Y	14.8%	6.4%	-4.8%	-6.4%	-9.5%	-3.1%	-4.8%	-5.3%	-2.1%	2.0%	-16.3%	-14.0%	-9.2%	-0.7%	5.7%	17.3%	28.0%	56.4%	59.8%	64.5%	64.48%
Assets 5Y	16.0%	16.5%	8.0%	8.4%	10.2%	2.4%	4.6%	-3.7%	-1.3%	-3.4%	-6.0%	-3.8%	-2.2%	2.1%	4.2%	8.4%	14.5%	36.0%	18.5%	20.9%	20.92%
Equity 3Y	-21.7%	-34.9%	-58.5%	—	—	—	—	—	—	—	—	—	—	-52.3%	39.8%	—	—	—	—	—	—
Book Value 3Y	-22.4%	-35.3%	-58.9%	—	—	—	—	—	—	—	—	—	—	-53.1%	37.2%	—	—	—	—	—	—
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.77	0.89	0.64	0.64	0.62	0.85	0.63	0.57	0.59	0.55	0.45	0.39	0.45	0.64	0.57	0.53	0.63	0.65	0.59	0.59	0.592
Earnings Stability	0.56	0.75	0.09	0.13	0.11	0.42	0.08	0.12	0.19	0.37	0.03	0.04	0.12	0.48	0.21	0.32	0.45	0.50	0.55	0.64	0.643
Margin Stability	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88	0.97	0.97	0.96	0.96	0.96	0.96	0.96	0.96	0.96	0.96	0.960
Rev. Growth Consistency	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.00	0.00	1.00	1.00	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0
Earnings Persistence	0.81	0.84	0.50	0.50	0.50	0.50	0.81	0.50	0.50	0.50	0.50	0.50	0.20	0.20	0.20	0.20	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00	0.00	0.00	0.00	0.000
ROE Trend	0.32	0.47	-12.23	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Gross Margin Trend	0.00	0.00	-0.00	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.05	-0.05	-0.06	-0.08	-0.07	-0.06	-0.04	-0.00	0.02	0.02	-0.01	-0.006
FCF Margin Trend	0.41	0.64	0.48	-0.57	-0.60	-0.39	-0.26	0.01	0.10	0.11	0.21	0.48	0.60	0.57	0.46	0.49	0.35	0.26	0.21	0.21	0.213
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	3.8%	2.2%	1.9%	1.7%	1.3%	1.27%
Internal Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	3.1%	14.2%	32.6%	1.4%	1.5%	-13.0%	-15.2%	7.7%	7.67%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	-0.65	-0.33	-0.00	0.80	0.86	1.26	1.17	0.88	0.88	0.23	0.34	0.86	2.76	1.80	0.96	0.67	0.60	0.21	0.22	0.25	0.247
FCF/OCF	0.88	0.89	-2.98	1.00	1.01	1.01	1.29	1.46	1.70	3.61	1.02	1.03	0.97	0.99	0.99	1.00	1.00	1.00	1.00	1.00	1.000
FCF/Net Income	snapshot only																				0.247
OCF/EBITDA	snapshot only																				0.844
CapEx/Revenue	0.8%	0.4%	0.9%	0.4%	0.4%	0.4%	11.8%	12.1%	11.4%	12.8%	0.1%	0.3%	0.2%	0.2%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
CapEx/Depreciation	snapshot only																				0.005
Accruals Ratio	-0.15	-0.17	-0.47	-0.10	-0.08	0.10	0.06	-0.04	-0.03	-0.15	-0.10	-0.02	-0.05	-0.10	0.01	0.19	0.24	0.86	0.84	0.67	0.666
Sloan Accruals	snapshot only																				-0.003
Cash Flow Adequacy	snapshot only																				6615.750
Earnings Quality Score	snapshot only																				0.250

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.0%	0.0%	0.00%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.7%	0.0%	0.00%
Net Buyback Yield	0.0%	0.0%	0.0%	-0.3%	-0.3%	-0.2%	-0.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.1%	-0.1%	-0.4%	0.0%	-0.7%	-0.67%
Total Shareholder Return	0.0%	0.0%	0.0%	-0.3%	-0.3%	-0.2%	-0.3%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.1%	-0.1%	-0.4%	0.0%	-0.7%	-0.67%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.05	1.03	0.99	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.95	0.98	0.99	0.99	3.01	2.99	3.76	3.762
Interest Burden (EBT/EBIT)	1.40	1.39	1.07	1.05	1.05	1.07	1.09	1.15	1.33	1.38	1.62	2.18	0.33	0.70	0.83	0.93	0.94	0.94	0.95	0.94	0.936
EBIT Margin	-0.07	-0.08	-0.95	-0.91	-0.88	-0.46	-0.32	-0.26	-0.14	-0.16	-0.10	-0.05	0.07	0.15	0.23	0.40	0.43	0.44	0.43	0.33	0.330
Asset Turnover	0.95	1.07	0.47	0.54	0.59	0.80	0.95	1.03	1.15	0.93	0.96	1.06	1.24	1.28	1.34	1.60	1.48	0.87	0.88	0.76	0.761
Equity Multiplier	3.08	4.31	4.29	5.12	10.13	18.00	-15.62	-7.71	-4.47	-5.95	-4.47	-4.23	-5.48	-11.09	-23.08	6.44	3.71	1.72	1.63	1.43	1.434

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$-0.85	$-1.05	$-4.94	$-4.91	$-4.78	$-3.39	$-2.57	$-2.18	$-1.40	$-1.44	$-1.13	$-0.81	$0.22	$0.97	$2.05	$5.39	$5.91	$19.48	$18.50	$16.45	$16.45
Book Value/Share	$2.91	$1.78	$0.40	$-0.21	$-1.15	$-0.79	$-1.40	$-1.62	$-1.83	$-1.64	$-1.81	$-1.70	$-0.83	$0.18	$1.02	$4.51	$6.14	$20.78	$20.31	$21.74	$22.96
Tangible Book/Share	$2.91	$1.78	$0.40	$-0.21	$-1.15	$-1.65	$-2.24	$-2.45	$-2.64	$-2.44	$-3.46	$-3.32	$-2.40	$-1.32	$-0.44	$3.08	$4.82	$19.47	$19.09	$16.94	$16.94
Revenue/Share	$8.62	$8.72	$4.95	$5.14	$5.17	$6.96	$7.47	$7.30	$7.59	$6.70	$6.87	$7.42	$8.92	$9.97	$11.18	$14.75	$14.73	$15.62	$15.23	$14.14	$14.93
FCF/Share	$0.48	$0.31	$-0.03	$-3.97	$-4.12	$-4.29	$-3.88	$-2.80	$-2.09	$-1.19	$-0.39	$-0.72	$0.59	$1.73	$1.94	$3.62	$3.56	$4.02	$4.03	$4.06	$4.28
OCF/Share	$0.55	$0.34	$0.01	$-3.95	$-4.10	$-4.27	$-3.01	$-1.92	$-1.23	$-0.33	$-0.38	$-0.70	$0.61	$1.75	$1.96	$3.62	$3.56	$4.02	$4.03	$4.06	$4.28
Cash/Share	$8.38	$7.30	$6.26	$5.18	$4.72	$3.37	$3.38	$3.71	$3.58	$3.26	$2.83	$2.80	$3.46	$4.30	$4.24	$5.97	$7.16	$8.22	$7.45	$4.87	$5.14
EBITDA/Share	$-0.52	$-0.66	$-4.62	$-4.60	$-4.49	$-3.12	$-2.30	$-1.82	$-0.98	$-0.97	$-0.63	$-0.28	$0.77	$1.59	$2.67	$6.02	$6.49	$6.98	$6.67	$4.80	$4.80
Debt/Share	$1.92	$1.79	$2.22	$2.07	$2.48	$2.40	$3.50	$3.50	$3.49	$3.47	$3.45	$3.44	$3.41	$3.33	$3.36	$3.36	$3.18	$2.83	$2.32	$2.04	$2.04
Net Debt/Share	$-6.46	$-5.52	$-4.04	$-3.11	$-2.25	$-0.96	$0.12	$-0.21	$-0.09	$0.21	$0.62	$0.64	$-0.05	$-0.96	$-0.88	$-2.61	$-3.98	$-5.40	$-5.13	$-2.83	$-2.83

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	3.453
Altman Z-Prime	snapshot only																				4.500
Piotroski F-Score	6	6	3	1	1	1	3	4	3	4	3	3	6	8	6	7	7	6	6	4	4
Beneish M-Score	-3.05	-3.14	-7.38	-3.36	-3.20	7.08	14.11	13.51	13.46	-3.37	-2.51	-1.71	-1.80	-2.25	-1.85	-0.61	-1.29	1.46	1.50	1.78	1.783
Ohlson O-Score	snapshot only																				-11.858
ROIC (Greenblatt)	snapshot only																				1.01%
Net-Net WC	snapshot only																				$4.60
EVA	snapshot only																				$290449407.23

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA
Credit Score	33.65	29.95	20.86	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	20.00	41.67	49.34	61.36	62.32	85.78	81.89	89.44	89.444
Credit Grade	snapshot only																				3
Credit Trend	snapshot only																				28.089
Implied Spread (bps)	snapshot only																				80.000
Industry Credit Rank	snapshot only																				88
Sector Credit Rank	snapshot only																				84

RIGL NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet